$386.03
0.29% today
NYSE, Nov 26, 02:12 pm CET
ISIN
US8636671013
Symbol
SYK

Stryker Stock News

Neutral
FXEmpire
6 days ago
Strong financial performance has investors eyeing Stryker Corporation (SYK) closely.
Neutral
PRNewsWire
7 days ago
FLOWER MOUND, Texas, USA, Nov. 19, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, unveiled the Oculan Lighting Platform, an innovative lighting solution designed to provide consistent, high-quality illumination, allowing surgeons to focus on delivering the highest standard of care. In today's operating rooms, where precision and accuracy are critical, even th...
Neutral
PRNewsWire
12 days ago
PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management portfolio.
Neutral
Seeking Alpha
28 days ago
Stryker Corporation. (NYSE:SYK ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Finance and Investor Relations Glenn Boehnlein - Vice President, Chief Financial Officer Conference Call Participants Robert Marcus - JPMorgan Lawrence Biegelsen - Wells Fargo Securities Joanne Wuensch - C...
Positive
Seeking Alpha
about one month ago
Stryker Corporation is a global leader in medical devices, with strong growth prospects driven by an aging population and technological advancements. SYK has a robust track record of double-digit earnings growth and high single-digit organic revenue growth, outperforming peers. Stryker's innovative products, like the Mako robot, and strategic acquisitions bolster its market position and future ...
Positive
Seeking Alpha
about one month ago
Stryker Corporation stock is recommended as a Buy due to its steady earnings growth, margin improvements, and strategic acquisitions, with a one-year price target 12.66% higher. Recent financial results show robust performance, with net sales up 8.5%, adjusted EPS up 10.6%, and a healthy balance sheet with reduced long-term debt. Stryker's growth prospects are supported by organic growth, acqui...
Positive
MarketBeat
about 2 months ago
Stryker NYSE: SYK is a medical device company that has risen to become the third-largest U.S. firm in the healthcare equipment and supplies industry. The company has often acquired other firms to boost its competitiveness and add capabilities.
Neutral
GlobeNewsWire
about 2 months ago
Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report its third quarter 2024 financial results on Tuesday, October 29, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the quarter ended September 30, 2024.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today